NASDAQ: ALT · Biotechnology
Over the past week, Altimmune (ALT) drew about 21 mentions across Reddit, X and news, and the read is an Adanos Sell. The crowd averages 41% bullish but is sharply divided: News runs 67% bullish while X sits at just 22%. Wall Street is more constructive, with 9 of 10 analysts rating ALT a buy.
There is little buzz around ALT this week and little agreement on direction, which is why it reads as a Sell.
Wall Street’s 90% buy share sits next to a crowd that ranges from X at 22% to News at 67%. No other tracker puts the two side by side.
10 analysts have weighed in: a Strong Buy consensus: 9 buy calls against 0 sell, with an average 12-month price target of $17.22.
The Adanos signal blends each source’s bullish ratio, source breadth, buzz intensity and 3-day momentum. This week bullish sits just below the neutral line, momentum is mixed and the 3 sources disagree sharply, so the read is a Sell.
Analysts sit 49 points above the crowd average of 41%, the professionals are more constructive than retail. The split is inside the crowd: News reads 67% bullish while X sits at 22%, a 45-point spread that single-source trackers miss.
Over the 30-day window, Altimmune (ALT) buzz held subdued around 29.9 while the price drifted up 13.5% across the period. The chart tracks how social and news attention moved against end-of-day price. Average daily trading volume across the displayed trading days is 3.9M shares. Over the last 7 trading days, ALT held roughly flat. Buzz activity in the recent week averaged 35.4 and was variable, swinging between 25.2 and 47.5. Recent volume is in line with the 30-day average, reflecting steady institutional and retail participation. Daily crowd sentiment leaned bullish on 10 of the 20 days with directional mentions, shown as the green, grey and red breakdown bars below the chart.
Signal metrics use the latest 7 days; contributor and breadth context uses the 30-day chart window.
No Polymarket data for this stock this week.
Query sentiment for ALT and 2001+ stocks from your terminal. Filter by source, timeframe and signal strength.
View CLIEmbed live ALT sentiment on your own site with drop-in web components.
View WidgetsThis week’s sentiment from Adanos, with fundamentals and analyst consensus. A quick-reference snapshot for Sep 11, 2026.
| Adanos signal | Sell |
|---|---|
| Analyst consensus | Strong Buy (9 / 1 / 0) |
| Crowd bullish (7d) | 41% |
| Avg price target | $17.22 |
| Most bullish source | News, 67% |
| Most bearish source | X, 22% |
| Sentiment spread | 45 pts |
| Mentions (7d) | 21 |
| Market cap | $640M |
| P/E · Forward P/E | n/a · 8.2 |
| EPS · Beta | -$0.76 · 0.2 |
| Revenue (TTM) | $31,000 · 0% margin |
| Industry | Biotechnology |
Based on aggregated sentiment from Reddit, X and News sources, Altimmune (ALT) currently carries an Adanos sell signal with 90/100 conviction. The current cross-source average reads 41% bullish across 3 active sources. Those sources contribute 21 tracked mentions over the last 7 days. This is a sentiment-based reading, not financial advice.
Reddit discussion around Altimmune (ALT) is fairly quiet with 9 mentions over the last 7 days; the 30-day context spans 13 tracked subreddits. The 7-day tone is 33% bullish; 3-day activity momentum is stable, suggesting steady attention.
The crowd reads bearish on Altimmune (ALT), averaging 41% bullish across 3 tracked sources over the last 7 days. The two ends of the range are News at 67% bullish and X at 22%, a 45-point spread. On the professional side, 9 of 10 analysts rate ALT a buy.
Of the 10 analysts covering Altimmune (ALT), 9 rate it a buy, 1 a hold and 0 a sell, for a strong buy consensus. The average price target is $17.22. That puts the street ahead of the crowd, which averages 41% bullish.
Altimmune (ALT)'s cross-source average is bearish at 41% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. Reddit reads 33% bullish, News reads 67% bullish and x coverage is the most negative at 22% bullish. The combined signal points to broad sell-side pressure with 90/100 conviction.
The cross-source average is bearish for Altimmune (ALT) at 41% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. The most bearish reading is x at 22% bullish. The sell signal carries 90/100 conviction.
Reddit is the dominant discussion channel with 9 mentions (43% of total volume). X contributes 9 mentions and News contributes 3 mentions. The cross-source average is bearish at 41% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish.
The Adanos signal blends bullish ratio, buzz score, source breadth and 3-day activity momentum into a single buy/sell reading. ALT's sell signal at 90/100 conviction reflects a bearish cross-source average at 41% bullish. Source readings are split: 1 source leans bullish and 2 sources lean bearish. It is a research shortcut, not financial advice.
The ALT sentiment page is regenerated from the latest 7-day tracking window at each build. Data reflects the most recent Reddit posts, tweets and news articles available in the current publishing cycle.
Peers are ranked first by matching the Sell signal, then by the closest bullish ratio. Discussion activity breaks any remaining ties.
Every data point on this page comes from the Adanos sentiment APIs. Get a free API key and start querying Reddit, X, News and Polymarket sentiment programmatically.
Get Free API Key